Ftse Mib
38.655,30
1,73%
DAX
22.986,82
2,01%
S&P 500
5.638,94
2,13%
NASDAQ
17.754,09
2,61%
Bitcoin
84.234,86
-0,13%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Seres Therapeutics Inc (MCRB) Seres Therapeutics Inc (MCRB) Notizie

MCRB

Seres Therapeutics (MCRB)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MCRB
DataOraFonteTitoloSimboloCompagnia
13/03/202516:43Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MCRBSeres Therapeutics Inc
13/03/202516:37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MCRBSeres Therapeutics Inc
13/03/202512:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MCRBSeres Therapeutics Inc
13/03/202512:00GlobeNewswire Inc.Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdatesNASDAQ:MCRBSeres Therapeutics Inc
04/03/202513:00GlobeNewswire Inc.Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025NASDAQ:MCRBSeres Therapeutics Inc
03/03/202513:00GlobeNewswire Inc.Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development ApproachNASDAQ:MCRBSeres Therapeutics Inc
20/02/202502:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
06/02/202514:00Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MCRBSeres Therapeutics Inc
16/01/202513:00GlobeNewswire Inc.Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST SaleNASDAQ:MCRBSeres Therapeutics Inc
09/01/202513:00GlobeNewswire Inc.Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate UpdatesNASDAQ:MCRBSeres Therapeutics Inc
16/12/202413:00GlobeNewswire Inc.Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare ConferenceNASDAQ:MCRBSeres Therapeutics Inc
09/12/202413:00GlobeNewswire Inc.FDA Grants Breakthrough Therapy Designation to Seres Therapeutics’ SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)NASDAQ:MCRBSeres Therapeutics Inc
22/11/202413:00GlobeNewswire Inc.Seres Therapeutics to Participate in Piper Sandler Healthcare ConferenceNASDAQ:MCRBSeres Therapeutics Inc
13/11/202416:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MCRBSeres Therapeutics Inc
13/11/202413:00GlobeNewswire Inc.Seres Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:MCRBSeres Therapeutics Inc
06/11/202413:00GlobeNewswire Inc.Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024NASDAQ:MCRBSeres Therapeutics Inc
15/10/202406:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MCRBSeres Therapeutics Inc
11/10/202422:34Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MCRBSeres Therapeutics Inc
01/10/202422:46Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MCRBSeres Therapeutics Inc
30/09/202423:15GlobeNewswire Inc.Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.ANASDAQ:MCRBSeres Therapeutics Inc
26/09/202422:01GlobeNewswire Inc.Seres Therapeutics Stockholders Approve Sale of VOWST™ to Nestlé Health Science; Sale Expected to Close on September 30NASDAQ:MCRBSeres Therapeutics Inc
13/09/202413:00GlobeNewswire Inc.Seres Therapeutics to Participate in Cantor 2024 Global Healthcare ConferenceNASDAQ:MCRBSeres Therapeutics Inc
12/09/202414:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MCRBSeres Therapeutics Inc
12/09/202413:00GlobeNewswire Inc.Seres Therapeutics Reports SER-155 Phase 1b Placebo-Controlled Cohort 2 Study Safety and Clinical Results in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT)NASDAQ:MCRBSeres Therapeutics Inc
26/08/202422:36Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:MCRBSeres Therapeutics Inc
15/08/202412:52Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:MCRBSeres Therapeutics Inc
13/08/202413:00GlobeNewswire Inc.Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:MCRBSeres Therapeutics Inc
06/08/202413:00GlobeNewswire Inc.Seres Therapeutics to Announce Second Quarter 2024 Financial Results and Business Update on August 13, 2024NASDAQ:MCRBSeres Therapeutics Inc
06/08/202413:00GlobeNewswire Inc.Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health ScienceNASDAQ:MCRBSeres Therapeutics Inc
07/06/202422:00GlobeNewswire Inc.Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:MCRBSeres Therapeutics Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:MCRB

La tua Cronologia

EU
SGSEV
Societe Generale SFH Sgs...
COIN
AGIBTC
SingularityNET
LATK
GLMBTC
Golem Network Token
BOV
CRIV4L
ALFA FINANC PN
BOV
ALOS3T
ALLOS
BOV
CGAS5R
COMGÁS PNA
EU
BFCGK
Banque Fed Cred Mutuel B...
BOV
APER3F
ALPER ON
EU
BPHBT
BNP Bond Fh0 Pct 20sep28
NASDAQ
ABKQWXX
Barclays Bank Plc Issuer...
NASDAQI
CX10PI
OMX Copenhagen Technolog...
MRTX
CXBTC
Cred
EU
AFDEF
Agence FSE de Developpem...
NASDAQ
ABNAFXX
Bofa Finance Llc Issuer ...
GATE
STRUSDT
Stater
GATE
SPAYETH
SpaceY Token
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci